Airway smooth muscle in asthma

Annual Review of Pathology: Mechanisms of Disease

Volumn 3, Issue , 2008, Pages 523-555

  Hershenson, Marc B ^a   Brown, Melanie ^b   Camoretti Mercado, Blanca ^b   Solway, Julian ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cytokines; Hyperplasia; Hypertrophy; Inflammation; Remodeling

Indexed keywords

AIRWAY OBSTRUCTION; ASTHMA; HUMAN; IMMUNOMODULATION; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW; SMOOTH MUSCLE;

ANIMALS; ASTHMA; HUMANS; MUSCLE, SMOOTH;

EID: 41749095876     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev.pathmechdis.1.110304.100213     Document Type: Review

References (243)

1. Moyer CF, Reinisch CL. 1984. The role of vascular smooth muscle cells in experimental autoimmune vasculitis. I. The initiation of delayed type hypersensitivity angiitis. Am. J. Pathol. 117:380-90
2. Libby P, Ordovas JM, Birinyi LK, Auger KR, Dinarello CA. 1986. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J. Clin. Invest. 78:1432-38
3. Ghaffar O, Hamid Q, Renzi PM, Allakhverdi Z, Molet S, et al. 1999. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 159:1933-42
4. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, et al. 1998. Interleukin-13: central mediator of allergie asthma. Science 282:2258-61
5. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, et al. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-63
6. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, et al. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8:885-89
7. Li L, Xia Y, Nguyen A, Lai YH, Feng L, et al. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162:2477-87
8. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, et al. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779-88
9. Baraldo S, Faffe DS, Moore PE, Whitehead T, McKenna M, et al. 2003. Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L1093-102
10. Gounni AS, Hamid Q, Rahman SM, Hoeck J, Yang J, Shan L. 2004. IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells. J. Immunol. 173:2771-79
11. Jarai G, Sukkar M, Garrett S, Duroudier N, Westwick J, et al. 2004. Effects of interleukin-1β, interleukin-13 and transforming growth factor-β on gene expression in human airway smooth muscle using gene microarrays. Eur. J. Pharmacol. 497:255-65
12. Moore PE, Church TL, Chism DD, Panettieri RA Jr, Shore SA. 2002. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L847-53
13. Nie M, Corbett L, Knox AJ, Pang L. 2005. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor γ agonists: interactions with glucocorticoids and β2-agonists. J. Biol. Chem. 280:2550-61
14. Peng Q, Matsuda T, Hirst SJ. 2004. Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle. Am. J. Respir. Crit. Care Med. 169:596-603
15. Zuyderduyn S, Hiemstra PS, Rabe KF. 2004. TGF-β differentially regulates TH2 cytokine-induced eotaxin and eotaxin-3 release by human airway smooth muscle cells. J. Allergy Clin. Immunol. 114:791-98
16. Berkman N, Krishnan VL, Gilbey T, Newton R, O'Connor B, et al. 1996. Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J. Respir. Crit. Care Med. 154:1804-11
17. Sukkar MB, Issa R, Xie S, Oltmanns U, Newton R, Chung KF. 2004. Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-γ and TNF-α and regulation by TGF-β and corticosteroids. Am. J. Physiol. Lung Cell Mol. Physiol. 287:L1230-40
18. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346:1699-705
19. Hakonarson H, Masked N, Carter C, Chuang S, Grunstein MM. 1999. Autocrine interaction between IL-5 and IL-1β mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 104:657-67
20. Whelan R, Kim C, Chen M, Leiter J, Grunstein MM, Hakonarson H. 2004. Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle. Eur. Respir. J. 24:559-67
21. Saunders MA, Mitchell JA, Seldon PM, Yacoub MH, Barnes PJ, et al. 1997. Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br. J. Pharmacol. 120:545-46
22. Elias JA, Wu Y, Zheng T, Panettieri R. 1997. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am. J. Physiol. 273:L648-55
23. Grunstein MM, Hakonarson H, Leiter J, Chen M, Whelan R, et al. 2001. Autocrine signaling by IL-10 mediates altered responsiveness of atopic sensitized airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 281:L1130-37
24. Grunstein MM, Hakonarson H, Leiter J, Chen M, Whelan R, et al. 2002. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L520-28
25. Gounni AS, Wellemans V, Yang J, Bellesort F, Kassiri K, et al. 2005. Human airway smooth muscle cells express the high affinity receptor for IgE (FcεRI): a critical role of Fc epsilon RI in human airway smooth muscle cell function. J. Immunol. 175:2613-21
26. Gounni AS. 2006. The high-affinity IgE receptor (FcεRI): a critical regulator of airway smooth muscle cells? Am. J. Physiol. Lung Cell Mol. Physiol. 291:L312-21
27. Hakonarson H, Carter C, Kim C, Grunstein MM. 1999. Altered expression and action of the low-affinity IgE receptor FcεRII (CD23) in asthmatic airway smooth muscle. J. Allergy Clin. Immunol. 104:575-84
28. Panettieri RA Jr, Lazaar AL, Pure E, Albelda SM. 1995. Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-α-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion. J. Immunol. 154:2358-65
29. Lazaar AL, Albelda SM, Pilewski JM, Brennan B, Pure E, Panettieri RA Jr. 1994. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J. Exp. Med. 180:807-16
30. Syed F, Panettieri RA Jr, Tliba O, Huang C, Li K, et al. 2005. The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells. Respir. Res. 6:9
31. Wang CC, Lin WN, Lee CW, Lin CC, Luo SF, et al. 2005. Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-κB in IL-1β-induced VCAM-1 expression in human tracheal smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 288:L227-37
32. Hughes JM, Arthur CA, Baracho S, Carlin SM, Hawker KM, et al. 2000. Human eosinophil-airway smooth muscle cell interactions. Mediators Inflamm. 9:93-99
33. Lazaar AL, Krymskaya VP, Das SK. 2001. VCAM-1 activates phosphatidylinositol 3-kinase and induces p120Cbl phosphorylation in human airway smooth muscle cells. J. Immunol. 166:155-61
34. Tliba O, Tliba S, Da Huang C, Hoffman RK, DeLong P, et al. 2003. Tumor necrosis factor α modulates airway smooth muscle function via the autocrine action of interferon β. J. Biol. Chem. 278:50615-23
35. McKay S, de Jongste JC, Saxena PR, Sharma HS. 1998. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-β1. Am. J. Respir. Cell Mol. Biol. 18:823-33
36. De S, Zelazny ET, Souhrada JF, Souhrada M. 1993. Interleukin-1 β stimulates the proliferation of cultured airway smooth muscle cells via platelet-derived growth factor. Am. J. Respir. Cell Mol. Biol. 9:645-51
37. Wen FQ, Liu X, Manda W, Terasaki Y, Kobayashi T, et al. 2003. TH2 cytokine-enhanced and TGF-β-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-γ and corticosteroids. J. Allergy Clin. Immunol. 111:1307-18
38. Kazi AS, Lotfi S, Goncharova EA, Tliba O, Amrani Y, et al. 2004. Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L539-45
39. Knox AJ, Corbett L, Stocks J, Holland E, Zhu YM, Pang L. 2001. Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J. 15:2480-88
40. Huber HL, Koessler KK. 1922. The pathology of bronchial asthma. Arch. Intern. Med. 30:689-760
41. Kountz WB, Alexander HC. 1928. Death from bronchial asthma. Arch. Pathol. Lab. Med. 5:1003-19
42. Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW. 1986. In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, β-adrenoeeptor agonists and theophylline. Br. J. Clin. Pharmacol. 22:669-76
43. Whicker SD, Armour CL, Black JL. 1988. Responsiveness of bronchial smooth muscle from asthmatic patients to relaxant and contractile agonists. Pulmonary Pharmacol. 1:25-31
44. Bai TR. 1991. Abnormalities in airway smooth muscle in fatal asthma. A comparison between trachea and bronchus. Am. Rev. Respir. Dis. 143:441-43
45. Zhang S, Smartt H, Holgate ST, Roche WR. 1999. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro coculture model of airway remodeling in asthma. Lab. Invest. 79:395-405
46. Howat WJ, Holgate ST, Lackie PM. 2002. TGF-β isoform release and activation during in vitro bronchial epithelial wound repair. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L115-23
47. Roche WR, Williams JH, Beasley R, Holgate ST. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1:520-24
48. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. 1989. Bronchial biopsies in asthma: an ultrastructural, quantitiative study and correlation with hyperreactivity. Am. Rev. Respir. Dis. 140:1745-53
49. Altraja A, Laitinen A, Virtanen I, Kampe M, Simonsson BG, et al. 1996. Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am. J. Respir. Cell Mol. Biol. 15:482-88
50. Laitinen LA, Laitinen A, Altraja A, Virtanen I, Kampe M, et al. 1996. Bronchial biopsy findings in intermittent or "early" asthma. J. Allergy Clin. Immunol. 98:S3-6
51. Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. 1990. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 3:507-11
52. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, et al. 1997. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 156:591-99
53. Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK. 1997. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am. J. Respir. Cell Mol. Biol. 16:664-73
54. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171:380-89
55. Larsen K, Tufvesson E, Malmstrom J, Morgelin M, Wildt M, et al. 2004. Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am. J. Respir. Crit. Care Med. 170:1049-56
56. Ollerenshaw SL, Woolcock AJ. 1992. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am. Rev. Respir. Dis. 145:922-27
57. Minshall EM, Leung DYM, Matin RJ, Song YL, Cameron L, et al. 1997. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17:326-33
58. Ohno I, Nitta Y, Yamauchi K, Hoshi H, Honma M, et al. 1996. Transforming growth factor β 1 (TGF β1) gene expression by eosinophils in asthmatic airway inflammation. Am. J. Respir. Cell Mol. Biol. 15:404-9
59. Tillie-Leblond I, Pugin J, Marquette C-H, Lamblin C, Saulnier F, et al. 1999. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am. J. Respir. Crit. Care Med. 159:487-94
60. Nomura A, Uchida Y, Sakamoto T, Ishii Y, Masuyama K, et al. 2002. Increases in collagen type I collagen synthesis in asthma: the role of eosinophils and transforming growth factor-β. Clin. Exp. Allergy 32:860-65
61. Dunhill MS, Massarella GR, Anderson JA. 1971. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis and in emphysema. Thorax 24:176
62. Takizawa T, Thurlbeck WM. 1971. Muscle and mucous gland size in the major bronchi of patients with chronic bronchitis, asthma, and asthmatic bronchitis. Am. Rev. Respir. Dis. 104:331-36
63. Heard BE, Hossain S. 1973. Hyperplasia of bronchial smooth muscle in asthma. J. Pathol. 110:319-32
64. Sobonya RE. 1984. Quantitative structural alterations in long-standing allergic asthma. Am. Rev. Respirat. Dis. 130:289-92
65. James AL, Pare PD, Hogg JC. 1989. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139:242-46
66. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. 1991. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 143:138-43
67. Ebina M, Takahashi T, Chiba T, Motomiya M. 1993. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am. Rev. Respir. Dis. 148:720-26
68. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, et al. 1999. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 160:1001-8
69. Carroll N, Elliot J, Morton A, James A. 1993. The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 147:405-10
70. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. 2003. Airway structural alterations selectively associated with severe asthma. Am J. Respir. Crit. Care Med. 167:1360-68
71. Woodraff PG, Dolganov GM, Ferrando RE, Donnelly S, Hays SR, et al. 2004. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J. Respir. Crit. Care Med. 169:1001-6
72. Krymskaya VP, Hoffman R, Eszterhas A, Ciocca V, Panettieri PA. 1997. TGF-β1 modulates EGF-stimulated phosphatidylinositol 3-kinase activity in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 273:L1220-L27
73. Cohen MD, Ciocca V, Panettieri RA Jr. 1997. TGF-β 1 modulates human airway smooth-muscle cell proliferation induced by mitogens. Am. J. Respir. Cell Mol. Biol. 16:85-90
74. Puddicombe SM, Torres-Lozano C, Richter A, Bucchieri F, Lordan JL, et al. 2003. Increased expression of p21waf cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 28:61-68
75. Sturrock A, Huecksteadt TP, Norman K, Sanders KA, Murphy TM, et al. 2007. Nox4 mediates TGF-β1-induced retinoblastoma protein phosphorylation, proliferation and hypertrophy in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 292:L1543-55
76. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. 1993. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 148:1220-25
77. Lambert RK, Wiggs BR, Kuwano K, Hogg JC, Pare PD. 1993. Functional significance of increased airway smooth muscle in asthma and COPD. J. Appl. Physiol. 74:2771-81
78. Cho SH, Seo JY, Choi DC, Yoon HJ, Cho YJ, et al. 1996. Pathological changes according to the severity of asthma. Clin. Exp. Allergy 26:1210-19
79. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. 1997. Airway remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 111:852-57
80. Boulet L-P, Laviolette M, Turcotte H, Cartier A, Dugas M, et al. 1997. Bronchial subepitheial fibrosis correlates with airway responsiveness to methacholine. Chest 112:45-52
81. Olivieri D, Chetta A, DD M, Bertorelli G, Casalina A, et al. 1997. Effect of short-term treatment with low-dose inhaled fluticasone proprionate on airway inflammation and remodelling in mild asthma: a placebo controlled study. Am. J. Respir. Crit. Care Med. 155:1864-71
82. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAulay A, et al. 1994. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am. J. Respir. Crit. Care Med. 150:17-22
83. Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M. 2003. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am. J. Respir. Crit. Care Med. 168:983-88
84. Brown PJ, Greville HW, Finucane KE. 1984. Asthma and irreversible airflow obstruction. Thorax 39:131-36
85. Braman SS, Kaemmerlen JT, Davis SM. 1991. Asthma in the elderly: a comparison between patients with recently acquired and long-standing disease. Am. Rev. Respir. Dis. 143:336-40
86. Kelleher MD, Abe MK, Chao TS, Jain M, Green JM, et al. 1995. Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis. Am. J. Physiol. 268:L894-901
87. Hirst SJ, Barnes PJ, Twort CH. 1996. PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells. Am. J. Physiol. 270:L415-28
88. Hirst SJ, Barnes PJ, Twort CH. 1992. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. Am. J Respir. Cell Mol. Biol. 7:574-81
89. Krymskaya VP, Hoffman R, Eszterhas A, Kane S, Ciocca V, Panettieri RA Jr. 1999. EGF activates ErbB-2 and stimulates phosphatidylinositol 3-kinase in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 276:L246-55
90. Panettieri RA, Yadvish PA, Kelly AM, Rubinstein NA, Kotlikoff MI. 1990. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am. J. Physiol. 259:L365-71
91. Stewart AG, Grigoriadis G, Harris T. 1994. Mitogenic actions of endothelin-1 and epidermal growth factor in cultured airway smooth muscle. Clin. Exp. Pharmacol. Physiol. 21:277-85
92. Panettieri RA Jr, Hall IP, Maki CS, Murray RK. 1995. α-Thrombin increases cytosolic calcium and induces human airway smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 13:205-16
93. Malarkey K, Chilvers ER, Lawson MF, Plevin R. 1995. Stimulation by endothelin-1 of mitogen-activated protein kinases and DNA synthesis in bovine tracheal smooth muscle cells. Br. J. Pharmacol. 116:2267-73
94. Shapiro PS, Evans JN, Davis RJ, Posada JA. 1996. The seven-transmembrane- spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-Jun NH2-terminal kinase groups of mitogen-activated protein kinases. J. Biol. Chem. 271:5750-54
95. Whelchel A, Evans J, Posada J. 1997. Inhibition of ERKactivation attenuates endothelin-stimulated airway smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 16:589-96
96. Walker TR, Moore SM, Lawson MF, Panettieri RAJ, Chilvers ER. 1998. Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation. Mol. Pharmacol. 54:1007-15
97. Vichi P, Whelchel A, Knot H, Nelson M, Kolch W, Posada J. 1999. Endothelin-stimulated ERK activation in airway smooth-muscle cells requires calcium influx and Raf activation. Am. J. Respir. Cell Mol. Biol. 20:99-105
98. Brown JK, Jones CA, Rooney LA, Caughey GH, Hall IP. 2002. Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L197-206
99. Amishima M, Munakata M, Nasuhara Y, Sato A, Takahashi T, et al. 1998. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am. J. Respir. Crit. Care Med. 157:1907-12
100. Ohno I, Nitta Y, Yamauchi K, Hoshi H, Honma M, et al. 1995. Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma. Am. J. Respir. Cell Mol. Biol. 13:639-47
101. Maruno K, Absood A, Said SI. 1995. VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells. Am. J. Physiol. 268:L1047-51
102. Karpova AY, Abe MK, Li J, Liu P, Rhee JM, et al. 1997. MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes. Am. J. Physiol. 272:L558-65
103. Lew DB, Dempsey BK, Zhao Y, Muthalif M, Fatima S, Malik KU. 1999. β-hexosaminidase-induced activation of p44/42 mitogen-activated protein kinase is dependent on p21Ras and protein kinase C and mediates bovine airway smooth-muscle proliferation. Am. J. Respir. Cell Mol. Biol. 21:111-18
104. Orsini MJ, Krymskaya VP, Eszterhas AJ, Benovic JL, Panettieri RA, Penn RB. 1999. MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. Am. J. Physiol. 277:L479-88
105. Herskowitz I. 1995. MAP kinase pathways in yeast: for mating and more. Cell 80:187-97
106. Treisman R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-15
107. Waskiewicz AJ, Cooper JA. 1995. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell. Biol. 7:798-805
108. Watanabe N, Madaule P, Reid T, Ishizaki T, Watanabe G, et al. 1997. p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small Gtpase and is a ligand for profilin. EMBO J. 16:3044-56
109. Watanabe G, Howe A, Lee R, Albanese C, Shu I, et al. 1996. Induction of cyclin D1 by simian virus 40 small T tumor antigen. Proc. Natl. Acad. Sci. USA 93:12861-66
110. Edgar BA, Lehner CF. 1996. Developmental control of cell cycle regulators: a fly's perspective. Science 274:1646-52
111. Elledge SJ. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-72
112. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science 264:1413-14
113. Yan M, Templeton DJ. 1994. Identification of 2 serine residues of MEK-1 that are differentially phosphorylated during activation by raf and MEK kinase. J. Biol. Chem. 269:19067-73
114. Ammit AJ, Kane SA, Panettieri RAJ. 1999. Activation of K-p21ras and N-p21ras, but not H-p21ras, is necessary for mitogen-induced airway smooth muscle proliferation. Am. J. Respir. Cell. Mol. Biol. 21:719-27
115. Page K, Li J, Hershenson MB. 1999. Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role of Ras. Am. J. Respir. Cell Mol. Biol. 20:1294-302
116. Whelchel A, Evans J, Posada J. 1997. Inhibition of ERK activation attenuates endothelin-stimulated airway smooth muscle prolifeation. Am. J. Respir. Cell Mol. Biol. 16:589-96
117. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, et al. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:23589-97
118. MAPK pathway. J. Biol. Chem. 271:20608-16
119. Ramakrishnan M, Musa NL, Li J, Liu P, Pestell RG, Hershenson MB. 1998. Catalytic activation of extracellular signal-regulated kinases induces cyclin D1 expression in airway smooth muscle. Am. J. Respir. Cell Mol. Biol. 18:736-40
120. Naureckas ET, Ndukwu IM, Halayko AJ, Maxwell C, Hershenson MB, Solway J. 1999. Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle. Am. J. Respir. Crit. Care Med. 160:2062-66
121. Cheng M, Sexl V, Sherr CJ, Roussel MF. 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95:1091-96
122. Weber JD, Hu W, Jefcoat SC Jr, Raben DM, Baldassare JJ. 1997. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272:32966-71
123. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, et al. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. GenesDev. 7:1559-71
124. Resnitzky D, Gossen M, Bujard H, Reed SI. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-79
125. Wymann MP, Zvelebil M, Laffargue M. 2003. Phosphoinositide 3-kinase signalling - which way to target? Trends Pharmacol. Sci. 24:366-76
126. Carpenter CL, Cantley LC. 1990. Phosphoinositide kinases. Biochemistry 29:11147-56
127. Lemmon MA, Ferguson KM, O'Brien R, Sigler PB, Schlessinger J. 1995. Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc. Natl. Acad. Sci. USA 92:10472-76
128. Page K, Li J, Wang Y, Kardia S, Pestell RG, Hershenson MB. 2000. Regulation of cyclin D1 expression and DNA synthesis by phosphatidylinositol 3-kinase in airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 23:436-43
129. Scott PH, Belham CM, al-Hafidh J, Chilvers ER, Peacock AJ, et al. 1996. A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells. Biochem. J. 318:965-71
130. Krymskaya VP, Penn RB, Orsini MJ, Scott PH, Plevin RJ, et al. 1999. Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation. Am. J. Physiol. Lung Cell. Mol. Physiol. 277:L65-78
131. Hawkins PT, Eguinoa A, Qiu R-G, Stokoe D, Cooke FT, et al. 1995. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr. Biol. 5:393-403
132. Hall A. 1998. Rho GTPases and the actin cytoskelton. Science 279:509-14
133. Wennstrom S, Hawkins P, Cooke F, Hara K, Yonesawa K, et al. 1994. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol. 4:385-93
134. Reif K, Nobes CD, Thomas G, Hall A, Cantrell DA. 1996. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 6:1445-55
135. Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, et al. 1999. Characterization of a Rac1 signaling pathway to cyclin D1 expression in airway smooth muscle cells. J. Biol. Chem. 274:22065-71
136. Bauerfeld CP, Hershenson MB, Page K. 2001. Cdc42, but not RhoA, regulates cyclin D1 expression in bovine tracheal myocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 280:L974-82
137. Abo A, Pick E, Hall A, Totty N, Teahan CG, Segal AW. 1991. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353:668-70
138. Abo A, Boyhan A, West I, Thrasher AJ, Segal AW. 1992. Reconstitution of neutrophil NADPH oxidase activity in the cell-free system by four components: p67-phox, p47-phox, p21rac1, and cytochrome b-245. J. Biol. Chem. 267:16767-70
139. Brar SS, Kennedy TP, Whorton AR, Murphy TM, Chitano P, Hoidal JR. 1999. Requirement for reactive oxygen species in serum-induced and platelet-derived growth factor-induced growth of airway smooth muscle. J. Biol. Chem. 274:20017-26
140. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, et al. 2002. NADPH oxidase promotes NF-κB activation and proliferation in human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L782-95
141. Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, et al. 2001. Airway smooth muscle cell proliferation is increased in asthma. Am J. Respir. Crit. Care Med. 164:474-77
142. Fernandes D, Guida E, Koutsoubos V, Harris T, Vadiveloo P, et al. 1999. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am. J. Respir. Cell Mol. Biol. 21:77-88
143. waf1/cip1 promoter in rat hepatoma cells. J. Biol. Chem. 273:1998-2007
144. Roth M, Johnson PR, Borger P, Bihl MP, Rudiger JJ, et al. 2004. Dysfunctional interaction of C/EBPα and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N. Engl. J. Med. 351:560-74
145. Woodruff PG, Dolganov GM, Ferrando RE, Donnelly S, Hays SR, et al. 2004. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am. J. Respir. Crit. Care Med. 169:1001-6
146. Blank RS, Thompson MM, Owens GK. 1988. Cell cycle versus density dependence of smooth muscle α actin expression in cultured rat aortic smooth muscle cells. J. Cell Biol. 107:299-306
147. Panettieri RA, Murray RK, DePalo LR, Yadvish PA, Kotlikoff MI. 1989. A human airway smooth muscle cell line that retains physiological responsiveness. Am. J. Physiol. 256:C329-35
148. Halayko AJ, Salari H, Ma X, Stephens NL. 1996. Markers of airway smooth muscle cell phenotype. Am. J. Physiol. 270:L1040-51
149. Mitchell RW, Halayko AJ, Kahraman S, Solway J, Wylam ME. 2000. Selective restoration of calcuim coupling to muscarinic M(3) receptors in contractile cultured airway myocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 278:L1091-100
150. Kaplan-Albuquerque N, Garat C, Desseva C, Jones PL, Nemenoff RA. 2003. Platelet-derived growth factor-BB-mediated activation of akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor. J. Biol. Chem. 278:39830-38
151. Halayko AJ, Kardia S, Stelmack GL, McConville J, Tam J, et al. 2004. Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am. J. Respir. Cell Mol. Biol. 31:266-75
152. Halayko AJ, Camoretti-Mercado B, Forsythe SM, Vieira JE, Mitchell RW, et al. 1999. Divergent differentiation paths in airway smooth muscle culture: induction of functionally contractile myocytes. Am. J. Physiol. 276:L197-206
153. Camoretti-Mercado B, Liu H, Halayko A, Forsythe S, Kyle J, et al. 2000. Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J. Biol. Chem. 275:30387-93
154. Zhou L, Li J, Goldsmith AM, Newcomb DC, Giannola DM, et al. 2004. Human bronchial smooth muscle cell lines show a hypertrophic phenotype typical of severe asthma. Am. J. Respir. Crit. Care Med. 169:703-11
155. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. 2002. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16:1472-87
156. Ivester CT, Tuxworth WJ, Cooper GIV, McDermott PJ. 1995. Contraction accelerates myosin heavy chain synthesis rates in adult cardiocytes by an increase in the rate of translational initiation. J. Biol. Chem. 270:21950-57
157. Nikcevic G, Heidkamp MC, Perhonen M, Russell B. 1999. Mechanical activity in heart regulates translation of α-myosin heavy chain mRNA but not its localization. Am. J. Physiol. Heart Circ. Physiol. 276:H2013-19
158. Morgan HE, Gordon EE, Kira Y, Chua BHL, Russo LA, et al. 1987. Biochemical mechanisms of cardiac hypertrophy. Annu. Rev. Physiol. 49:533-43
159. Sartorelli V, Fulco M. 2004. Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Sci. STKE 244:re11
160. Glass DJ. 2003. Molecular mechanisms modulating muscle mass. Trends Mol. Med. 9:344-50
161. Hesketh JE, Campbell GP, Lobley GE, Maltin CA, Acamovic F, Palmer RM. 1992. Stimulation of actin and myosin synthesis in rat gastrocnemius muscle by clenbuterol; evidence for translational control. Comp. Biochem. Physiol. C 102:23-27
162. Welle S, Bhatt K, Thornton CA. 1999. Stimulation of myofibrillar synthesis by exercise is mediated by more efficient translation of mRNA. J. Appl. Physiol. 86:1220-25
163. Geisterfer A, Peach M, Owens G. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-56
164. Goldsmith AM, Bentley JK, Zhou L, Jia Y, Bitar KN, et al. 2006. Transforming growth factor-β induces airway smooth muscle hypertrophy. Am. J. Respir. Cell Mol. Biol. 34:247-54
165. Camoretti-Mercado B, Fernandes DJ, Dewundara S, Churchill J, Ma L, et al. 2006. Inhibition of transforming growth factor β-enhanced serum response factor-dependent transcription by SMAD7. J. Biol. Chem. 281:20383-92
166. Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N. 1996. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15:658-64
167. Brunn GJ, Hudson CC, Sekuli A, Williams JM, Hosoi H, et al. 1997. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277:99-101
168. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. 1997. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1909-20
169. Scheper GC, Morrice NA, Kleijn M, Proud CG. 2001. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells. Mol. Cell. Biol. 21:743-54
170. Sonenberg N, Gingras AC. 1998. The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr. Opin. Cell Biol. 10:268-75
171. Svitkin YV, Pause A, Haghighat A, Pyronnet S, Witherell G, et al. 2001. The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure. RNA 7:382-94
172. Welsh GI, Miller CM, Loughlin AJ, Price NT, Proud CG. 1998. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 421:125-30
173. Leevers SJ, Weinkove D, MacDougall LK, Hafen E, Waterfield MD. 1996. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15:6584-94
174. Verdu J, Buratovich MA, Wilder EL, Birnbaum MJ. 1999. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat. Cell Biol. 1:500-6
175. Zhang H, Stallock JP, Ng JC, Reinhard C, Neufeld TP. 2000. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14:2712-24
176. Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, Thomas G. 1999. Drosophila S6 kinase: a regulator of cell size. Science 285:2126-29
177. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, et al. 1998. Protein Kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279:710-14
178. Cheatham L, Monfar M, Chou M, Blenis J. 1995. Structural and functional analysis of pp70S6k. Proc. Natl. Acad. Sci. USA 92:11696-700
179. Toker A, Newton AC. 2000. Cellular signaling: pivoting around PDK-1. Cell 103:185-88
180. Vanhaesebroeck B, Alessi DR. 2000. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346:561-76
181. Foukas LC, Shepherd PR. 2004. eIF4E binding protein 1 and H-Ras are novel substrates for the protein kinase activity of class-I phosphoinositide 3-kinase. Biochem. Biophys. Res. Commun. 319:541-49
182. Herbert TP, Tee AR, Proud CG. 2002. The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J. Biol. Chem. 277:11591-96
183. Gao X, Pan D. 2001. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15:1383-92
184. Potter CJ, Huang H, Xu T. 2001. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 105:357-68
185. Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK. 2001. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105:345-55
186. Inoki K, Li Y, Zhu T, Wu J, Guan KL. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4:648-57
187. Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, et al. 2002. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 4:699-704
188. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. 2002. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell. Biol. 10:151-62
189. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. 2002. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. USA 99:13571-76
190. Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, et al. 2002. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 277:30958-67
191. Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. 2003. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13:1259-68
192. Inoki K, Li Y, Xu T, Guan KL. 2002. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17:1829-34
193. Mach KE, Furge KA, Albright CF. 2000. Loss of Rhb1, a Rheb-Related GTPase in fission yeast, causes growth arrest with a terminal phenotype similar to that caused by nitrogen starvation. Genetics 155:611-22
194. Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, et al. 2004. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6:1122-28
195. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, et al. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127:125-37
196. Yang Q, Inoki K, Ikenoue T, Guan K-L. 2006. Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20:2820-32
197. Hietakangas V, Cohen SM. 2007. Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth. Genes Dev. 21:632-37
198. Alt JR, Cleveland JL, Hannink M, Diehl JA. 2000. Phosphorylation- dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:3102-14
199. Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes. Dev. 12:3499-5511
200. Rossig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeier S. 2002. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J. Biol. Chem. 277:9684-89
201. Zhou L, Goldsmith AM, Bentley JK, Jia Y, Rodriguez ML, et al. 2005. 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. Am. J. Respir. Cell Mol. Biol. 33:195-202
202. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, et al. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418:426-30
203. Howard TD, Postma DS, Jongepier H, Moore WC, Koppelman GH, et al. 2003. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J. Allergy Clin. Immunol. 112:717-22
204. Lind DL, Choudhry S, Ung N, Ziv E, Avila PC, et al. 2003. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am. J. Respir. Crit. Care Med. 168:1312-16
205. Raby BA, Silverman EK, Kwiatkowski DJ, Lange C, Lazarus R, Weiss ST. 2004. ADAM33 polymorphisms and phenotype associations in childhood asthma. J. Allergy Clin. Immunol. 113:1071-78
206. Umland SP, Garlisi CG, Shah H, Wan Y, Zou J, et al. 2003. Human ADAM33 messenger RNA expression profile and post-transcriptional regulation. Am. J. Respir. Cell Mol. Biol. 29:571-82
207. Powell RM, Wicks J, Holloway JW, Holgate ST, Davies DE. 2004. The splicing and fate of ADAM33 transcripts in primary human airways fibroblasts. Am. J. Respir. Cell Mol. Biol. 31:13-21
208. Gilpin BJ, Loechel F, Mattel M-G, Engvall E, Albrechtsen R, Wewer UM. 1998. A novel, secreted form of human ADAM 12 (meltrin a) provokes myogenesis in vivo. J Biol. Chem. 273:157-66
209. Bai TR. 1990. Abnormalities in airway smooth muscle in fatal asthma. Am. Rev. Respir. Dis. 141:552-57
210. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, et al. 2003. Indirect airway challenges. Eur. Respir. J. 21:1050-68
211. Black JL. 1996. Role of airway smooth muscle. Am J. Respir. Crit. Care Med. 153:S2-4
212. Thomson NC. 1987. In vivo versus in vitro human airway responsiveness to different pharmacologic stimuli. Am. Rev. Respir. Dis. 136:S58-62
213. Hershenson MB, Aghili S, Punjabi N, Hernandez C, Ray DW, et al. 1992. Hyperoxia-induced airway hyperresponsiveness and remodeling in immature rats. Am. J. Physiol. 262:L263-69
214. Hershenson MB, Kelleher MD, Naureckas ET, Abe MK, Rubinstein VJ, et al. 1994. Hyperoxia increases airway cell S-phase traversal in immature rats in vivo. Am. J. Respir. Cell Mol. Biol. 11:296-303
215. Hershenson MB, Abe MK, Kelleher MD, Naureckas ET, Garland A, et al. 1994. Recovery of airway structure and function after hyperoxic exposure in immature rats. Am J. Respir. Crit. Care Med. 149:1663-69
216. Hershenson MB, Wylam ME, Punjabi N, Umans JG, Schumacker PT, et al. 1994. Exposure of immature rats to hyperoxia increases tracheal smooth muscle stress generation in vitro. J. Appl. Physiol. 76:743-49
217. Hershenson MB, Garland A, Kelleher MD, Zimmermann A, Hernandez C, Solway J. 1992. Hyperoxia-induced airway remodeling in immature rats. Correlation with airway responsiveness. Am. Rev. Respir. Dis. 146:1294-300
218. Hakonarson H, Herrick DJ, Serrano PG, Grunstein MM. 1997. Autocrine role of interleukin 1β in altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest 99:117-24
219. Hakonarson H, Halapi E, Whelan R, Gulcher J, Stefansson K, Grunstein MM. 2001. Association between IL-1β/TNF-α-induced glucocorticoid- sensitive changes in multiple gene expression and altered responsiveness in airway smooth muscle. Am. J. Respir. Cell Mol. Biol. 25:761-71
220. Deshpande DA, Dogan S, Walseth TF, Miller SM, Amrani Y, et al. 2004. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am. J. Respir. Cell Mol. Biol. 31:36-42
221. 2+ signaling contributes to airway smooth muscle hyperresponsiveness. FASEB J. 17:452-54
222. 2+ sensitization of myosin light chain20 phosphorylation. Mol. Pharmacol. 63:714-21
223. 2+ sensitization of bronchial smooth muscle contraction in airway hyperresponsiveness. J. Smooth Muscle Res. 40:155-67
224. Hashimoto K, Peebles RS Jr, Sheller JR, Jarzecka K, FurlongJ, et al. 2002. Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor. Thorax 57:524-27
225. Chiba Y, Sakai H, Misawa M. 2001. Augmented acetylcholine-induced translocation of RhoA in bronchial smooth muscle from antigen-induced airway hyperresponsive rats. Br. J. Pharmacol. 133:886-90
226. Ma X, Cheng Z, Kong H, Wang Y, Unruh H, et al. 2002. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am. J. Physiol. Lung Cell Mol. Physiol. 283:L1181-89
227. Solway J, Fredberg JJ. 1997. Perhaps airway smooth muscle dysfunction contributes to asthmatic bronchial hyperresponsiveness after all. Am. J. Respir. Cell Mol. Biol. 17:144-46
228. Barnes PJ, Pride NB. 1983. Dose-response curves to inhaled β-adrenoceptor agonists in normal and asthmatic subjects. Br. J. Clin. Pharmacol. 15:677-82
229. Shore SA, Laporte J, Hall IP, Hardy E, Panettieri RA Jr. 1997. Effect of IL-1β on responses of cultured human airway smooth muscle cells to bronchodilator agonists. Am. J. Respir. Cell. Mol. Biol. 16:702-12
230. Lahiri T, Moore PE, Baraldo S, Whitehead TR, McKenna MD, et al. 2002. Effect of IL-1β on CRE-dependent gene expression in human airway smooth muscle cells. Am. J. Physiol. Lung. Cell. Mol. Physiol. 283:L1239-46
231. Laporte JD, Moore PE, Abraham JH, Maksym GN, Fabry B, et al. 1999. Role of ERK MAP kinases in responses of cultured human airway smooth muscle cells to IL-1β. Am. J. Physiol. 277:L943-51
232. Laporte JD, Moore PE, Panettieri RA, Moeller W, Heyder J, Shore SA. 1998. Prostanoids mediate IL-1β-induced β-adrenergic hyporesponsiveness in human airway smooth muscle cells. Am. J. Physiol. 275:L491-501
233. Hakonarson H, Herrick DJ, Serrano PG, Grunstein MM. 1996. Mechanism of cytokine-induced modulation of β-adrenoceptor responsiveness in airway smooth muscle. J. Clin. Invest. 97:2593-600
234. Hakonarson H, Herrick DJ, Grunstein MM. 1995. Mechanism of impaired β-adrenoceptor responsiveness in atopic sensitized airway smooth muscle. Am. J. Physiol. 269:L645-52
235. Koto H, Mak JC, Haddad EB, Xu WB, Salmon M, et al. 1996 Mechanisms of impaired β-adrenoceptor-induced airway relaxation by interleukin-1β in vivo in the rat. J. Clin. Invest. 98:1780-87
236. Laporte JC, Moore PE, Baraldo S, Jouvin MH, Church TL, et al. 2001. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 164:141-48
237. Shore SA, Moore PE. 2003. Regulation of β-adrenergic responses in airway smooth muscle. Respir. Physiol. Neurobiol. 137:179-95
238. Ober C, Leavitt SA, Tsalenko A, Howard TD, Hoki DM, et al. 2000. Variation in the interleukin 4-receptor α gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am. J. Hum. Genet. 66:517-26
239. Lakser OJ, Lindeman RP, Fredberg JJ. 2002. Inhibition of the p38 MAP kinase pathway destabilizes smooth muscle length during physiological loading. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L1117-21
240. Dowell ML, Lakser OJ, Gerthoffer WT, Fredberg JJ, Stelmack GL, et al. 2005. Latrunculin B increases force fluctuation-induced relengthening of ACh-contracted, isotonically shortened canine tracheal smooth muscle. J. Appl. Physiol. 98:489-97
241. Dulin NO, Fernandes DJ, Dowell M, Bellam S, McConville J, et al. 2003. What evidence implicates airway smooth muscle in the cause of BHR? Clin. Rev. Allergy Immunol. 24:73-84
242. Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S. 2006. Bronchial thermoplasty for asthma. Am J. Respir. Crit. Care Med. 173:965-69
243. Cox G, Thomson N, Sperb-Rubin A, Niven R, Corris PA, et al. 2007. Asthma control during the year after bronchial thermoplasty. New Engl. J. Med. 356:1327-37